| __timestamp | Supernus Pharmaceuticals, Inc. | Veracyte, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 122045000 | 38190000 |
| Thursday, January 1, 2015 | 144427000 | 49503000 |
| Friday, January 1, 2016 | 215003000 | 65085000 |
| Sunday, January 1, 2017 | 302238000 | 71953000 |
| Monday, January 1, 2018 | 408897000 | 92008000 |
| Tuesday, January 1, 2019 | 392755000 | 120368000 |
| Wednesday, January 1, 2020 | 520397000 | 117483000 |
| Friday, January 1, 2021 | 579775000 | 219514000 |
| Saturday, January 1, 2022 | 667238000 | 296536000 |
| Sunday, January 1, 2023 | 607521000 | 361051000 |
Unveiling the hidden dimensions of data
In the competitive landscape of biotechnology, Veracyte, Inc. and Supernus Pharmaceuticals, Inc. have showcased remarkable revenue trajectories over the past decade. Since 2014, Supernus Pharmaceuticals has consistently outpaced Veracyte, with its revenue growing by over 400% by 2023. In contrast, Veracyte has seen an impressive growth of nearly 850% during the same period, reflecting its dynamic expansion strategy.
By 2023, Supernus Pharmaceuticals reported a revenue of approximately $607 million, a slight dip from its peak in 2022. Meanwhile, Veracyte's revenue surged to around $361 million, marking a significant leap from its modest beginnings. This growth narrative highlights the evolving strategies and market adaptations of these two companies, offering insights into their future potential in the biotech sector.
Revenue Insights: Gilead Sciences, Inc. and Supernus Pharmaceuticals, Inc. Performance Compared
Revenue Insights: GSK plc and Supernus Pharmaceuticals, Inc. Performance Compared
Revenue Showdown: BeiGene, Ltd. vs Supernus Pharmaceuticals, Inc.
Revenue Insights: Pharming Group N.V. and Supernus Pharmaceuticals, Inc. Performance Compared
Revenue Insights: Corcept Therapeutics Incorporated and Veracyte, Inc. Performance Compared
Breaking Down Revenue Trends: Telix Pharmaceuticals Limited vs Supernus Pharmaceuticals, Inc.
Comparing Revenue Performance: TG Therapeutics, Inc. or Supernus Pharmaceuticals, Inc.?
Annual Revenue Comparison: Veracyte, Inc. vs Bausch Health Companies Inc.
Annual Revenue Comparison: Veracyte, Inc. vs Mesoblast Limited
Breaking Down Revenue Trends: Veracyte, Inc. vs Galapagos NV
Comparing Revenue Performance: Supernus Pharmaceuticals, Inc. or Galapagos NV?
Comparing Revenue Performance: Supernus Pharmaceuticals, Inc. or Evotec SE?